August 31, 2016 2:09 AM ET

Biotechnology

Company Overview of Foundation Medicine, Inc.

Executive Profile

Todd R. Golub M.D.

Founding Advisor, Foundation Medicine, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 7 different industries.

See Board Relationships
----

Background

Dr. Todd R. Golub, M.D., serves as Scientific Founder at H3 Biomedicine Inc. Dr. Golub is the Founding Director of the Cancer Program at the Broad Institute of Harvard and MIT, and also serves as the Institute’s Chief Scientific Officer. Dr. Golub is also the Charles A. Dana Investigator at the Dana-Farber Cancer Institute, Professor of Pediatrics at Harvard Medical School, and an investigator at the Howard Hughes Medical Institute. Dr. Golub is internationally known ...

Corporate Headquarters

150 Second Street
Cambridge, Massachusetts 02141

United States

Phone: 617-418-2200
Fax: 617-418-2290

Board Members Memberships

Director

Education

BA 1985
Carleton College
MD 1989
University Of Chicago - Pritzker School Of Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Dirk van den Boom Ph.D.Chief Executive Officer, President, Director and Member of Science Committee
Sequenom Inc.
$644.2K
Elazar Rabbani Ph.D.Co-Founder, Chairman, Chief Executive Officer and Secretary
Enzo Biochem Inc.
$555.5K
Gajus V. Worthington Co-Founder, Chief Executive Officer and Director
Fluidigm Corporation
$504.7K
Douglas M. VanOort Chairman of the Board and Chief Executive Officer
Neogenomics Inc.
$1.1M
R. Bradley Gray Chief Executive Officer, President and Director
NanoString Technologies, Inc.
$470.9K
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Foundation Medicine, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.